Sourcing Decisions for Goods with Potentially Imperfect Quality under the Presence of Supply Disruption

Laura Wagner, Mustafa Çagri Gürbüz

Abstract

Dispensers (pharmacies, hospitals etc.), time and again, are faced with multiple uncertainties like demand variability, supply disruptions etc. These periods of uncertainties are exploited by some distributors to breach regulated supply chains and push sub-quality and/or non-deceptive counterfeit medicines, forcing dispensers to identify and implement measures for detection to mitigate social and financial costs. In this paper, we attempt to study dispensers’ operational replenishment policies, during times of such uncertainties, under two counterfeit detection methods: a) Post-consumption detection — Counterfeit identification based on end-consumer and medical personnel’s feedback b) Inspection prior to circulation— implementing a track-and-trace system to find the origin of doubtful medicines at the time of purchasing. In each of the two situations, we determine which strategy --single sourcing, multi-sourcing or waiting for shortage to end-- is valuable to safeguard against spurious drugs, and quantify the optimal procurement allocation to each source in a multi-supplier and multi-period setting. Intriguingly, we found cases where a cost-minimizing dispenser may lean more on post-consumption detection than inspection prior to circulation.

References

  1. Bate, R., Zhe Jin, G., and Mathur, A. (2012). Counterfeit or substandard? assessing price and non-price signals of drug quality.
  2. Chesney MA, Ickovics J, H. F. S. G. R. J. (1999). Adherence: a necessity for successful hiv combination therapy. AIDS (London, England), 13(Suppl A):271-8.
  3. Dai, Y., Zhou, S. X., and Xu, Y. (2012). Competitive and collaborative quality and warranty management in supply chains. Production and Operations Management, 21(1):129-144.
  4. Ebel, T., George, K., Larsen, E., Shah, K., and Ungerman, D. (2013). Building New Strength in the Healthcare Supply Chain. Technical report.
  5. Federgruen, A. and Yang, N. (2011). Technical noteprocurement strategies with unreliable suppliers. Operations Research, 59(4):1033-1039.
  6. Grossman, G. M. and Shapiro, C. (1988). Counterfeitproduct trade. Working paper, National Bureau of Economic Research.
  7. Gürler, Ü. and Parlar, M. (1997). An inventory problem with two randomly available suppliers. Operations Research, 45(6):904-918.
  8. Hellerman, C. (2012). Fda commissioner talks counterfeit drugs. CNN.
  9. Huang, W., Kulkarni, V., and Swaminathan, J. M. (2008). Managing the inventory of an item with a replacement warranty. Management Science, 54(8):1441-1452.
  10. Liu, K., Li, J.-A., and Lai, K. K. (2004). Single period, single product newsvendor model with random supply shock. European Journal of Operational Research, 158(3):609 - 625.
  11. Lybecker, K. M. (2007). Rx roulette: combatting counterfeit pharmaceuticals in developing nations. Managerial and Decision Economics, 28(4-5):509-520.
  12. Murthy, D. and Djamaludin, I. (2002). New product warranty: A literature review. International Journal of Production Economics, 79(3):231 - 260.
  13. Parlar, M. and Perry, D. (1996). Inventory models of future supply uncertainty with single and multiple suppliers. Naval Research Logistics, 43(2):191-210.
  14. Pew-Health-Group (2011). After heparin: Protecting consumers from the risks of substandard and counterfeit drugs.
  15. PSI (2012). Counterfeit situation: Incident trends.
  16. Soo-Haeng, C., Fang, X., and Tayur, S. R. (2011). Combating strategic counterfeiters in licit and illicit supply chains. Working paper.
  17. Staake, T., Frdric, T., and Fleisch, E. (2009). The emergence of counterfeit trade: a literature review. European Journal of Marketing, 43(3):320-349.
  18. Tomlin, B. (2006). On the value of mitigation and contingency strategies for managing supply chain disruption risks. Management Science, 52(5):639-657.
  19. Veeraraghavan, S. and Scheller-Wolf, A. (2008). Now or later: A simple policy for effective dual sourcing in capacitated systems. Operations Research, 56(4):850-864.
  20. WHO (2010). Medicines: counterfeit medicines. Fact sheet No 275.
  21. Zhang, J., L. Jeff, H., and Rachel Q., Z. (2012). Fighting strategies in a market with counterfeits. Annals of Operations Research, 192(1):49-66.
  22. Zhang, R. (2011). Essays on Strategies of Fighting Counterfeits and Inventory Management. PhD thesis, Hong Kong University of Science and Technology.
Download


Paper Citation


in Harvard Style

Wagner L. and Gürbüz M. (2014). Sourcing Decisions for Goods with Potentially Imperfect Quality under the Presence of Supply Disruption . In Doctoral Consortium - DCORES, (ICORES 2014) ISBN Not Available, pages 10-17


in Bibtex Style

@conference{dcores14,
author={Laura Wagner and Mustafa Çagri Gürbüz},
title={Sourcing Decisions for Goods with Potentially Imperfect Quality under the Presence of Supply Disruption},
booktitle={Doctoral Consortium - DCORES, (ICORES 2014)},
year={2014},
pages={10-17},
publisher={SciTePress},
organization={INSTICC},
doi={},
isbn={Not Available},
}


in EndNote Style

TY - CONF
JO - Doctoral Consortium - DCORES, (ICORES 2014)
TI - Sourcing Decisions for Goods with Potentially Imperfect Quality under the Presence of Supply Disruption
SN - Not Available
AU - Wagner L.
AU - Gürbüz M.
PY - 2014
SP - 10
EP - 17
DO -